These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9205834)

  • 1. Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
    Saletu B; Anderer P; Semlitsch HV
    Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():12-21. PubMed ID: 9205834
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
    Grossmann W; Standl A; May U
    Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
    [No Abstract]   [Full Text] [Related]  

  • 4. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
    Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F
    Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditory long latency event-related potentials in Alzheimer's disease and multi-infarct dementia.
    Neshige R; Barrett G; Shibasaki H
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1120-5. PubMed ID: 3225596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of organic brain syndrome with nicergoline given once a day].
    Ladurner G; Erhart P; Erhart C; Scheiber V
    Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicergoline: parallel evolution of clinical trial methodology and drug development in dementias.
    Crook TH
    Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():22-6. PubMed ID: 9205835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of primary dementia based on modern concepts].
    Nervenarzt; 1995 May; 66(5 Suppl):1-4. PubMed ID: 9131089
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
    Herrmann WM; Stephan K; Gaede K; Apeceche M
    Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantified-EEG in normal aging and dementias.
    d'Onofrio F; Salvia S; Petretta V; Bonavita V; Rodriguez G; Tedeschi G
    Acta Neurol Scand; 1996 May; 93(5):336-45. PubMed ID: 8800344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ginkgo biloba special extract EGb 761--an anti-dementia drug].
    Hörr R; Kieser M
    Fortschr Med; 1998 Jan; 116(3):39-40. PubMed ID: 9522547
    [No Abstract]   [Full Text] [Related]  

  • 14. Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment.
    Zappoli R; Arnetoli G; Paganini M; Versari A; Battaglia A; Grignani A; Sacchetti G
    Neuropsychobiology; 1987; 18(3):149-54. PubMed ID: 3453431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroencephalography as a diagnostic tool in dementia; a review.
    Rosén I
    Acta Neurol Scand Suppl; 1996; 168():63-70. PubMed ID: 8997423
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):305-25. PubMed ID: 2127674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brainstem auditory evoked potentials in patients with multi-infarct dementia and dementia of the Alzheimer type.
    Tachibana H; Takeda M; Sugita M
    Int J Neurosci; 1989 Oct; 48(3-4):325-31. PubMed ID: 2583949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementia.
    Martin-Loeches M; Gil P; Jimenez F; Exposito FJ; Miguel F; Cacabelos R; Rubia FJ
    Biol Psychiatry; 1991 Feb; 29(3):211-23. PubMed ID: 2015328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis.
    Bès A; Orgogozo JM; Poncet M; Rancurel G; Weber M; Bertholom N; Calvez R; Stehlé B
    Eur J Neurol; 1999 May; 6(3):313-22. PubMed ID: 10210912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG power spectra and cognitive change in geriatric psychiatry: a longitudinal study.
    Sloan EP; Fenton GW
    Electroencephalogr Clin Neurophysiol; 1993 Jun; 86(6):361-7. PubMed ID: 7686470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.